TRSGOSLN003: Intraoperative Examination of Sentinel Node in Endometrial Cancer (TRSGO-SLN-003)

Sponsor
Ankara University (Other)
Overall Status
Completed
CT.gov ID
NCT04560491
Collaborator
(none)
208
1
52.9
3.9

Study Details

Study Description

Brief Summary

More than half of the cases with macrometastatic sentinel lymph node (SLN) have non-SLN metastasis and leaving these nodes in-situ may impair the survival. This study assessed the diagnostic accuracy of intraoperative SLN frozen section examination and scrape cytology as a possible solution for management of SLN positive patients. Clinical early stage endometrial cancer patients who underwent SLN algorithm and intraoperative frozen section or scrape cytology to evaluate SLN status for metastasis were analyzed retrospectively. Intraoperative examination findings were compared with final pathology results and diagnostic accuracy of frozen section and scrape cytology were evaluated.

Condition or Disease Intervention/Treatment Phase
  • Diagnostic Test: Intraoperative examination of sentinel node

Detailed Description

Frozen section: Lymph nodes up to 2 mm were embedded as a whole. Lymph nodes between 2-5 mm were cut in half along their long axis and nodes larger than 5 mm were sliced in neat, parallel slices at 2-3 mm intervals-slicing was perpendicular to the long axis of the node. Then whole of the SLNs were stained with hematoxylin and eosin (H&E) and examined by frozen section.

Scrape Cytology: SLNs were cut into 3-mm-thick pieces along their long axis. If the lymph node was smaller than 3 mm, it was cut in half. Both sides of the pieces were scraped separately by an edge of a glass slide or a lancet gently. Obtained materials were smeared immediately onto a slide and placed in ethanol for fixation. Then, all slides were stained with H&E and examined.

The results were reported to the surgeon as positive (metastatic) or negative with the numbers of lymph nodes. After intraoperative examination, lymph nodes were put into formalin solution and sent for final pathologic examination.

Data analyses were performed using SPSS Version 21.0 (IBM Corporation, Armonk, NYC, USA). Shapiro-Wilk test was performed to determine whether the data were normally distributed. Descriptive statistics of continuous variables were compared between groups using Mann-Whitney U test. The Chi-square test or Fisher's exact test (when chi-square test assumptions do not hold due to low expected cell counts) were used to compare categorical variables between groups. Continuous variables were presented as median and min-max values, whereas categorical variables were presented as number and percentage. A p value of <0.05 was considered statistically significant. Performance of each protocol to predict treatment success was assessed using confidence intervals with respect to sensitivity, specificity, positive predictive value, and negative predictive value.

Study Design

Study Type:
Observational
Actual Enrollment :
208 participants
Observational Model:
Case-Control
Time Perspective:
Retrospective
Official Title:
Intraoperative Examination of Sentinel Node for The Decision of Further Lymphadenectomy in Clinical Early Stage Endometrial Cancer: A Diagnostic Study of Turkish Gynecologic Oncology Group (TRSGO-SLN-003)
Actual Study Start Date :
Feb 1, 2016
Actual Primary Completion Date :
Apr 1, 2020
Actual Study Completion Date :
Jun 30, 2020

Arms and Interventions

Arm Intervention/Treatment
Frozen section

Patients underwent intraoperative sentinel node examination by frozen section

Diagnostic Test: Intraoperative examination of sentinel node
Intraoperative examination of sentinel node by either frozen section or scrape cytology to detect metastasis and decide for further lymphadenectomy.

Scrape cytology

Patients underwent intraoperative sentinel node examination by scrape cytology

Diagnostic Test: Intraoperative examination of sentinel node
Intraoperative examination of sentinel node by either frozen section or scrape cytology to detect metastasis and decide for further lymphadenectomy.

Outcome Measures

Primary Outcome Measures

  1. Sensitivity for the diagnosis of metastatic lymph node intraoperatively [intraoperative test]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Patients with apparently early stage endometrial cancer whose SLNs were evaluated intraoperatively were included to this study
Exclusion Criteria:
  • Patients with gross metastatic disease

  • Patients who had contraindications to dyes (iodine allergy or hepatic impairments)

Contacts and Locations

Locations

Site City State Country Postal Code
1 Ankara University Ankara Turkey 06610

Sponsors and Collaborators

  • Ankara University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
salih taskin, Assoc. Professor, Ankara University
ClinicalTrials.gov Identifier:
NCT04560491
Other Study ID Numbers:
  • TRSGO SLN-003
First Posted:
Sep 23, 2020
Last Update Posted:
Sep 23, 2020
Last Verified:
Sep 1, 2020
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Sep 23, 2020